Suppr超能文献

小肠细菌过度生长的诊断与治疗:巴西胃肠病学联合会官方立场文件

DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.

作者信息

Silva Bruno César da, Ramos Gabriela Piovezani, Barros Luisa Leite, Ramos Ana Flávia Passos, Domingues Gerson, Chinzon Décio, Passos Maria do Carmo Friche

机构信息

Hospital da Bahia, Divisão de Gastroenterologia, Salvador, BA, Brasil.

Faculdade Evangélica Mackenzie do Paraná, Divisão de Gastroenterologia, Curitiba, PR, Brasil.

出版信息

Arq Gastroenterol. 2025 Feb 17;62:e24107. doi: 10.1590/S0004-2803.24612024-107. eCollection 2025.

Abstract

BACKGROUND

Small intestinal bacterial overgrowth (SIBO) is a condition characterized by an abnormal increase in bacterial population in the small intestine, leading to symptoms such as bloating, abdominal pain, distension, diarrhea, and eventually malabsorption. The diagnosis and management of SIBO remain challenging due to overlapping symptoms with other gastrointestinal disorders such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and coeliac disease.

OBJECTIVE

This article aims to review current evidence on the diagnosis and treatment of SIBO, with a focus on strategies suitable for the Brazilian healthcare system.

METHODS

A comprehensive literature review was performed, focusing on clinical guidelines, randomized controlled trials, and cohort studies concerning SIBO. Diagnostic methods, including breath tests and direct aspiration techniques, were critically analyzed. Treatment approaches, including antibiotics, dietary modifications, and probiotics, were reviewed. The recommendations were formulated based on a panel of gastroenterologists, members of the Brazilian Federation of Gastroenterology (FBG), with approval from the majority of the members.

RESULTS

Breath tests using glucose and lactulose remain the most commonly used non-invasive diagnostic tools, though they are subject to limitations such as false positives and false negatives. Treatment with rifaximin is effective in most cases of SIBO, while systemic antibiotics like metronidazole and ciprofloxacin are alternatives. Probiotics and dietary interventions, particularly low FODMAP diets, can complement antibiotic therapy. Long-term follow-up is essential due to the recurrence rate, which is common in SIBO patients.

CONCLUSION

Standardizing SIBO diagnosis and treatment in Brazil is essential to reduce diagnostic delays and optimize care, especially given the disparities and heterogeneity in clinical practice across the country. This article provides evidence-based recommendations to guide clinical practice. Further research is needed to refine diagnostic methods, explore novel treatment strategies, and better understand the specific characteristics of the Brazilian population.

摘要

背景

小肠细菌过度生长(SIBO)是一种以小肠内细菌数量异常增加为特征的病症,可导致腹胀、腹痛、腹部膨隆、腹泻等症状,并最终引起吸收不良。由于SIBO与其他胃肠道疾病(如炎症性肠病(IBD)、肠易激综合征(IBS)和乳糜泻)症状重叠,其诊断和管理仍然具有挑战性。

目的

本文旨在综述当前关于SIBO诊断和治疗的证据,重点关注适用于巴西医疗保健系统的策略。

方法

进行了全面的文献综述,重点关注有关SIBO的临床指南、随机对照试验和队列研究。对诊断方法,包括呼气试验和直接抽吸技术进行了严格分析。对治疗方法,包括抗生素、饮食调整和益生菌进行了综述。这些建议是由巴西胃肠病学联合会(FBG)成员组成的胃肠病学家小组制定的,并得到了大多数成员的批准。

结果

使用葡萄糖和乳果糖的呼气试验仍然是最常用的非侵入性诊断工具,尽管它们存在假阳性和假阴性等局限性。利福昔明治疗在大多数SIBO病例中有效,而甲硝唑和环丙沙星等全身性抗生素是替代药物。益生菌和饮食干预,特别是低FODMAP饮食,可以补充抗生素治疗。由于复发率在SIBO患者中很常见,长期随访至关重要。

结论

在巴西标准化SIBO的诊断和治疗对于减少诊断延迟和优化护理至关重要,特别是考虑到该国临床实践中的差异和异质性。本文提供了基于证据的建议以指导临床实践。需要进一步研究以完善诊断方法、探索新的治疗策略并更好地了解巴西人群的具体特征。

相似文献

本文引用的文献

5
Aetiology, diagnosis and management of small intestinal bacterial overgrowth.小肠细菌过度生长的病因、诊断与管理
Frontline Gastroenterol. 2022 Jul 12;14(2):149-154. doi: 10.1136/flgastro-2022-102163. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验